These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6143634)

  • 1. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.
    Jennings G; Bobik A; Oddie C; Restall R
    Clin Pharmacol Ther; 1984 May; 35(5):594-603. PubMed ID: 6143634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
    Tangø M; Carlsen JE; Trap-Jensen J
    Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist.
    Detry JM; Decoster PM; Brasseur LA
    Eur Heart J; 1983 Aug; 4(8):584-91. PubMed ID: 6139282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.
    Sato H; Inoue M; Matsuyama T; Ozaki H; Shimazu T; Takeda H; Ishida Y; Kamada T
    Circulation; 1987 Jan; 75(1):213-20. PubMed ID: 2878742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of xamoterol in Shy-Drager syndrome.
    Obara A; Yamashita H; Onodera S; Yahara O; Honda H; Hasebe N
    Circulation; 1992 Feb; 85(2):606-11. PubMed ID: 1346511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV; Jensen HK; Faergeman O
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic and metabolic effects of xamoterol in exercising dogs.
    Fischer G; Schneider W; Grohs JG; Ehrendorfer S; Raberger G
    Eur J Pharmacol; 1990 Feb; 177(1-2):19-27. PubMed ID: 2140326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    McCaffrey PM; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
    Erlemeier HH; Kupper W; Bleifeld W
    Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of xamoterol (ICI 118,587) in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Br J Clin Pharmacol; 1984 Oct; 18(4):597-601. PubMed ID: 6148960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
    Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
    Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The partial agonist activity of xamoterol (ICI 118,587) studied by heart rate response in pithed rats.
    Hashimoto T; Kondo K; Shiina A; Toyo-Oka T; Kawasaki K; Kimura K; Hosoda S
    Jpn Circ J; 1988 Jan; 52(1):60-5. PubMed ID: 2896255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.